Related Experiment Video
Updated: Nov 18, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
The role of vaccines in combatting antimicrobial resistance
Francesca Micoli1, Fabio Bagnoli2, Rino Rappuoli3
1GSK Vaccines Institute for Global Health, Siena, Italy.
Abstract:
The use of antibiotics has enabled the successful treatment of bacterial infections, saving the lives and improving the health of many patients worldwide. However, the emergence and spread of antimicrobial resistance (AMR) has been highlighted as a global threat by different health organizations, and pathogens resistant to antimicrobials cause substantial morbidity and death. As resistance to multiple drugs increases, novel and effective therapies as well as prevention strategies are needed. In this Review, we discuss evidence that vaccines can have a major role in fighting AMR. Vaccines are used prophylactically, decreasing the number of infectious disease cases, and thus antibiotic use and the emergence and spread of AMR. We also describe the current state of development of vaccines against resistant bacterial pathogens that cause a substantial disease burden both in high-income countries and in low- and medium-income countries, discuss possible obstacles that hinder progress in vaccine development and speculate on the impact of next-generation vaccines against bacterial infectious diseases on AMR.
Insights
Vaccines can significantly combat antimicrobial resistance (AMR) by preventing bacterial infections, thereby reducing antibiotic use. This review explores vaccine development against resistant pathogens and their impact on global health.
Area of Science:
- Infectious Diseases
- Microbiology
- Vaccinology
Background:
- Antimicrobial resistance (AMR) poses a significant global health threat, leading to increased morbidity and mortality.
- Rising resistance to multiple drugs necessitates novel therapeutic and preventive strategies.
Purpose of the Study:
- To review the evidence supporting the role of vaccines in combating AMR.
- To discuss the development status of vaccines targeting resistant bacterial pathogens.
- To explore obstacles and future impacts of vaccines on AMR.
Main Methods:
- Literature review of existing research on vaccines and AMR.
- Analysis of vaccine development pipelines for resistant bacterial pathogens.
- Discussion of challenges and future prospects in vaccine-mediated AMR control.
Main Results:
- Vaccines can reduce infectious disease incidence, consequently decreasing antibiotic consumption and AMR spread.
- Vaccine development is ongoing for key resistant bacterial pathogens affecting diverse global populations.
- Several obstacles impede vaccine progress, but next-generation vaccines hold promise for AMR impact.
Conclusions:
- Vaccines represent a crucial prophylactic strategy to mitigate the global threat of AMR.
- Continued investment and research in vaccine development are essential for controlling resistant bacterial infections.
- Future vaccines are expected to play a pivotal role in reducing the burden of AMR worldwide.
More Related Videos
06:54Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Development of Antibiotic Resistance
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biological Methods for Microbial Control
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...